Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Effect of Hot Spring Therapy on Autonomic Nervous System and Exercise Performance During Altitude Training

23 de junho de 2026 atualizado por: Ziyue Ou, Macao Polytechnic University

A Randomized Controlled Trial to Investigate the Effects of Balneotherapy on Cardiac Autonomic Regulation and Exercise Performance in Healthy Adolescents Undergoing Real 1600-meter Altitude Training and Athlete Training.

This randomized controlled trial aims to investigate the effects of balneotherapy (hot spring bathing) on cardiac autonomic nervous system function and exercise performance in healthy athletes undergoing high-altitude training. Participants will be randomly assigned to the intervention group (receiving hot spring baths three times per week (38°C, 20 minutes) combined with high-altitude training), the control group (receiving routine recovery protocols combined with high-altitude training), or the hot water immersion group (receiving hot water baths three times per week (38°C, 20 minutes) combined with high-altitude training). Primary outcome measures include heart rate variability (HRV) indices and exercise performance indicators. Secondary outcomes include blood lactate, peripheral oxygen saturation (SpO2), and subjective fatigue. These findings may provide evidence for non-pharmacological interventions to enhance high-altitude training adaptation and exercise recovery.

Visão geral do estudo

Tipo de estudo

Intervencional

Inscrição (Real)

27

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

      • Macao, China
        • Macao Polytechnic University

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Filho

Aceita Voluntários Saudáveis

Sim

Descrição

Inclusion Criteria:

  • Male or female aged 11-17years
  • Regular endurance training (≥3 sessions/week) for ≥2 years
  • No history of altitude exposure >2000m in the past 3 months
  • No contraindications to hot water immersion (e.g., uncontrolled hypertension, severe cardiovascular disease, open wounds, pregnancy)
  • Ability to provide written informed consent- Willingness to abstain from other recovery modalities (e.g., massage, cryotherapy, compression garments) during the study period

Exclusion Criteria:

  • History of cardiovascular, respiratory, renal, or endocrine disorders
  • Current use of medications affecting autonomic function (e.g., beta-blockers, anticholinergics)- History of syncope or heat intolerance
  • Acute musculoskeletal injury within the past 6 months- Regular use of sauna, hot tub, or spa within the past month
  • Pregnancy or breastfeeding (for female participants)- Shift work or trans-meridian travel within 2 weeks prior to baseline assessment
  • Alcohol consumption >14 units/week or smoking

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Comparador Ativo: Natural Recovery Group
Control group participants will undergo the same altitude training protocol (altitude 1600 meters) for 4 weeks. After each training session, participants will receive standard recovery procedures, including 20 minutes of passive rest in a thermoneutral environment (room temperature 24°C), supplemented with mild hydration and self-selected stretching. No hydrothermal intervention will be provided.
Control group participants will undergo the same altitude training protocol (altitude 1600 meters) for 4 weeks. After each training session, participants will receive standard recovery procedures, including 20 minutes of passive rest in a thermoneutral environment (room temperature 24°C), supplemented with mild hydration and self-selected stretching. No hydrothermal intervention will be provided.
Outros nomes:
  • NR
Comparador Ativo: Hot water immersion group
The hot water immersion group will undergo a 4-week altitude training at 1600 meters above sea level. Subjects will receive a 20-minute hot water immersion (daily tap water, 38°C±1°C) in a standardized indoor hot spring facility. The immersion protocol involves soaking the body below the chest for 20 minutes, followed by a 10-minute rest before leaving the facility. Three times per week.
The hot water immersion group will undergo a 4-week altitude training at 1600 meters above sea level. Subjects will receive a 20-minute hot water immersion (daily tap water, 38°C±1°C) in a standardized indoor hot spring facility. The immersion protocol involves soaking the body below the chest for 20 minutes, followed by a 10-minute rest before leaving the facility. Three times per week.
Outros nomes:
  • Hwi
Experimental: Hot Spring Immersion Group
The hot spring immersion group will undergo a 4-week high-altitude training at an altitude of 1600 meters. Subjects will receive a 20-minute hot spring therapy (natural hot spring water, 38°C ± 1°C) in a standardized indoor hot spring facility. The immersion protocol involves soaking the body below the chest for 20 minutes, followed by a 10-minute rest before leaving the facility. Three times per week.
The hot spring immersion group will undergo a 4-week high-altitude training at an altitude of 1600 meters. Subjects will receive a 20-minute hot spring therapy (natural hot spring water, 38°C ± 1°C) in a standardized indoor hot spring facility. The immersion protocol involves soaking the body below the chest for 20 minutes, followed by a 10-minute rest before leaving the facility. Three times per week.
Outros nomes:
  • HSI

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Heart Rate Variability (HRV) - RMSSD
Prazo: Baselines were measured at the formal start of the experiment, at night during the 2nd, 3rd, and 4th weeks (post-intervention) after ascending the plateau, and post-tests were conducted one week after descending the plateau.
Root mean square of successive differences (RMSSD) between normal heartbeats, measured from a 5-minute seated ECG recording in a quiet, temperature-controlled (22-24°C) room after 15 minutes of rest. A higher RMSSD value indicates stronger parasympathetic activity. Unit: milliseconds (ms). Baseline, Week 2, Week 3 (post-intervention).
Baselines were measured at the formal start of the experiment, at night during the 2nd, 3rd, and 4th weeks (post-intervention) after ascending the plateau, and post-tests were conducted one week after descending the plateau.

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
HRV - SDNN
Prazo: Baselines were measured at the formal start of the experiment, at night during the 2nd, 3rd, and 4th weeks (post-intervention) after ascending the plateau, and post-tests were conducted one week after descending the plateau.
Standard deviation of NN intervals (normal-to-normal R-R intervals), reflecting overall autonomic modulation. Unit: milliseconds (ms). Baseline, Week 2, Week 3, Week4, post-tests
Baselines were measured at the formal start of the experiment, at night during the 2nd, 3rd, and 4th weeks (post-intervention) after ascending the plateau, and post-tests were conducted one week after descending the plateau.
Peripheral Oxygen Saturation (SpO2)
Prazo: one month.
Resting peripheral oxygen saturation measured via fingertip pulse oximeter after 10 minutes of seated rest. Unit: percentage (%)
one month.
Rating of Perceived Exertion (RPE)
Prazo: one month.
Borg 6-20 scale rating of perceived exertion recorded immediately after each training session. Higher scores indicate greater subjective effort. Unit: score (6-20). Daily during intervention
one month.
Maximum oxygen uptake
Prazo: The baseline measurement was taken before the official start of the experiment, and the post-test was conducted one week after descending from the plateau.
Testing maximum oxygen uptake on a rowing ergometer combined with a cardiopulmonary function tester. Protocol: Using a graded incremental protocol to test maximal oxygen uptake (VO2max). Units: mL·kg-1 ·min-1. Baseline, Week 5.
The baseline measurement was taken before the official start of the experiment, and the post-test was conducted one week after descending from the plateau.
30-second anaerobic power.
Prazo: The tests are scheduled before entering the plateau (baseline), during the 4th week of plateau training, and 1 week after leaving the plateau.
Perform a 30-s all-out test on a rowing ergometer. Protocol: sprint at maximum effort to measure the 30-second average power. Record power. Units: watt. Baseline, Week 4,1 week after altitude training.
The tests are scheduled before entering the plateau (baseline), during the 4th week of plateau training, and 1 week after leaving the plateau.

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

10 de janeiro de 2026

Conclusão Primária (Real)

7 de março de 2026

Conclusão do estudo (Real)

8 de março de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

14 de maio de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

19 de maio de 2026

Primeira postagem (Real)

27 de maio de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

26 de junho de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

23 de junho de 2026

Última verificação

1 de janeiro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • 202502AS100005

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

INDECISO

Descrição do plano IPD

The current research project has not yet been completed, and the data have not been publicly released. After publication, sharing will be decided on a case-by-case basis.

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever